Furthermore, our study discovered that PD-L1, but not CTLA4, is expressed on the cancer cell surface and anti-PD-L1 scFv from CF33-hNIS-antiPDL1-infected cells significantly blocked PD-L1 on cancer cells. Here, CTLA4 is linked to cancer.